Safety Pharmacology Society, Board of Directors Meeting January 21, February 18, March 10, 2008 Ian MacKenzie (President), Rick Briscoe (Vice President), Kristy Bruse (Vice Presidentelect), JoAnne Saye (Secretary), Paul Harrison (Secretary-Elect), Derek Leishman (Treasurer), Marc Bailie, Alan Bass, Tom Beck, Henry Holzgrefe, Mary Jeanne Kallman, Alison Templeton, Hugo Vargas, Rob Wallis, Leslie Patmore, and Brian Guth (Past President) Web Site Update. Dr. Bruse and the Web Site Committee have been regularly working with AIM to update the website. The Annual meeting page has been updated. The board has approved a summary document of the board minutes to be posted on the web site as a way of better communicating with the SPS members. Web Forum Update. Dr. Vargas and Dr. Bell are looking into the feasibility of developing Web Forum/Blog. Program Committee Meeting Update. Dr. Briscoe informed the Board that the agenda for the 2008 annual meeting is completed and posted on Web site. Annual Meeting Venue. Dr. Guth told the Board that the venue committee had met recently and made the first cut for possible sites for 2011 in Europe. These sites will now be investigated in more detail to determine how facilities and prices compare and what best meets the needs of the society. Strategic Items. Dr. MacKenzie asked the Board members to consider how various subcommittees and programs/projects can be best utilized to enhance the society, both present and future. By-laws Revision. Dr. Bruse summarized an additional change to the by-laws: The immediate past president has voting rights and only 4 Board of Directors will be replaced annually. This will maintain an odd number of voting members. The Board approved this change. The By-law revision suggestions have been presented to the membership for a vote. VII. ECG Tox White Paper. Dr. Guth informed the Board that he received all contributions and he will synthesize the material into a cohesive manuscript and send out to the group to evaluate. VIII. Continuing Education Credits/Certification Subcommittee Update. This committee discussed several options. There is great interest within the Board to develop some form of accreditation for Safety Pharmacology. Membership feedback regarding interest in such an effort would be greatly appreciated. 1